Showing results (51-60 of 65) with videos related to
Sort By:
Pageof 7
Psychopharmacology|March 19, 2004
MDMA ("ecstasy"), methamphetamine and their combination: long-term changes in social interaction and neurochemistry in the ratKelly J Clemens, Petra S Van Nieuwenhuyzen, Kong M Li, et al.Brain Structure & Function|July 15, 2026
Efferent projections of topographically distinct relaxin family peptide receptor-3 (RXFP3) lateral hypothalamus/zona incerta cellsBrandon K Richards, Alexander I J Kilby, Jennifer L Cornish, et al.Proteomics|September 3, 2016
Extended exposure to sugar and/or caffeine produces distinct behavioral and neurochemical profiles in the orbitofrontal cortex of rats: Implications for neural functionJane L Franklin, Mehdi Mirzaei, Travis A Wearne, et al.Journal of Proteome Research|September 7, 2023
Proteomic Analysis Reveals the Neurotoxic Effects of Chronic Methamphetamine Self-Administration-Induced Cognitive Impairments and the Role of Melatonin-Enhanced Restorative Process during Methamphetamine WithdrawalTanthai Polvat, Tanya Prasertporn, Piyada Na Nakorn, et al.Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|November 25, 2003
Chronic fluoxetine treatment partly attenuates the long-term anxiety and depressive symptoms induced by MDMA ('Ecstasy') in ratsMurray R Thompson, Kong M Li, Kelly J Clemens, et al.Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|May 17, 2022
Oxytocin as an adolescent treatment for methamphetamine addiction after early life stress in male and female ratsSarah J Baracz, Katherine J Robinson, Amanda L Wright, et al.Proteomics|December 2, 2015
Quantitative shotgun proteomics reveals extensive changes to the proteome of the orbitofrontal cortex in rats that are hyperactive following withdrawal from a high sugar dietJane L Franklin, Mehdi Mirzaei, Travis A Wearne, et al.Journal of Psychopharmacology (Oxford, England)|September 28, 2018
Cannabidiol treatment reduces the motivation to self-administer methamphetamine and methamphetamine-primed relapse in ratsGracie L Hay, Sarah J Baracz, Nicholas A Everett, et al.Addiction Biology|August 25, 2010
Systemically administered oxytocin decreases methamphetamine activation of the subthalamic nucleus and accumbens core and stimulates oxytocinergic neurons in the hypothalamusDean S Carson, Glenn E Hunt, Adam J Guastella, et al.Psychopharmacology|April 18, 2003
Increased anxiety and "depressive" symptoms months after MDMA ("ecstasy") in rats: drug-induced hyperthermia does not predict long-term outcomesIain S McGregor, Clint G Gurtman, Kirsten C Morley, et al.Pageof 7